Table 4 Summary of molecular alterations at baseline (Study 2)
| Â | Eradicated group (%) ( n =22) | Non-eradicated group (%) ( n =19) | P -value |
|---|---|---|---|
MSI | 22 (100) | 19 (100) | — |
hMLH1 | 5 (22.7) | 3 (15.8) | 0.70a |
CDKN2A | 1 (4.5) | 0 (0) | >0.99a |
APC | 0 (0) | 3 (15.8) | 0.09a |
mAb Das-1 reactivity | 15 (68.2) | 13 (68.4) | 0.99 |